1.
J Microbiol Immunol Infect
; 49(1): 127-30, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25556047
RESUMO
We investigated differences in outcomes between 68 children hospitalized with macrolide-sensitive Mycoplasma pneumoniae pneumonia (MSMP group) and 25 children hospitalized with macrolide-resistant M. pneumoniae pneumonia (MRMP group). In the MRMP group, 19 children received macrolides and clinical failure occurred in six of which five had pneumonia progression during therapy.
